Immunocytochemical detection of progesterone receptor by monoclonal KD-68 antibody in operable breast cancer: Correlations with biochemical assay, pathological features and cell proliferative rate-Reference-Cited by-同舟云学术

Immunocytochemical detection of progesterone receptor by monoclonal KD-68 antibody in operable breast cancer: Correlations with biochemical assay, pathological features and cell proliferative rate

Published:1989-11 Issue:11 Volume:25 Page:1595-1602
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Bevilacqua Pierantonio,Pea Maurizio,Gasparini Giampietro

Publisher

Elsevier BV

Subject

Oncology

Reference44 articles.

1. Predicting response to endocrine therapy in human breast cancer: a hypothesis;Horwitz;Science,1975

2. Progesterone receptor in rabbit uterus;Rao,1973

3. Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer;Kiang;N Engl J Med,1978

4. Estrogen receptors and breast cancer: prognostic and therapeutic implications;Gapinski;Surgery,1980

5. Role of progesterone receptors in breast cancer;McGuire;Semin Oncol,1985

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of different antibodies for detection of progesterone receptor in breast cancer;Steroids;2002-08

2. Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma;Breast Cancer Research and Treatment;1996-06

3. Hormonrezeptorbestimmung am Mammakarzinomgewebe Vergleich neuer immunhistologischer Techniken mit der biochemischen Rezeptortestung;Der Pathologe;1995-07-01

4. Immunohistochemical Detection of Hormone Receptors in Breast Carcinomas (ER-ICA, PgR-ICA): Prognostic Usefulness and Comparison with the Biochemical Radioactive-Ligand-Binding Assay (DCC);Gynecologic Oncology;1994-05

5. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.;Journal of Clinical Oncology;1994-03